drugset / Trial / NCT00886782
A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine safety, tolerability and maximum tolerated dose of BMS-863233 in subjects advanced and/or Metastatic solid tumors.
Timeline
- Start
- 2009-05-31
- Primary completion
- 2010-08-04
- Completion
- 2010-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-863233 | Small molecule | — | Oral |